Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy [0.03%]
基于个体患者数据的匹配调整间接比较与倾向性评分匹配估计治疗效应的作用效果分析
Emily C L Wong,Parambir S Dulai,John K Marshall et al.
Emily C L Wong et al.
YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel Disease [0.03%]
YouTube在克罗恩病和溃疡性结肠炎饮食管理中的作用：内容分析研究
Konstantinos Gkikas,Mhairi Wan,Vaios Svolos et al.
Konstantinos Gkikas et al.
Background: Patients with inflammatory bowel disease (IBD) often use the Internet to seek information beyond that received from healthcare professionals. This study assessed the perceptions of YouTube presenters on the ro...
Jonah H Gorodensky,Sasha Bernatsky,Waqqas Afif et al.
Jonah H Gorodensky et al.
Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study [0.03%]
vedolizumab对炎症性肠病肠外表现的影响：一项描述性的、回顾性的真实世界研究结果
Uri Kopylov,Johan Burisch,Shomron Ben-Horin et al.
Uri Kopylov et al.
Background: Patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, may develop extraintestinal manifestations (EIMs). The EMOTIVE study aimed to analyze the effect of vedolizumab...
Multicenter Study
Inflammatory bowel diseases. 2023 Nov 2;29(11):1713-1722. DOI:10.1093/ibd/izad075 2023
Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn's Disease: An Experience of 2 IBD Centers [0.03%]
ustekinumab维持治疗中较高的血药浓度与克罗恩病内镜疗效的关系：来自两家炎症性肠病中心的经验
Ciarán McDonald,Hilary Kerr,Eimear Gibbons et al.
Ciarán McDonald et al.
Background: Ustekinumab (UST), a human monoclonal antibody that binds the p40 subunit of interleukin 12 (IL-12) and IL-23, is licensed for induction and maintenance therapy of moderate to severe inflammatory bowel disease...
Observational Study
Inflammatory bowel diseases. 2024 Mar 1;30(3):423-428. DOI:10.1093/ibd/izad073 2024
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index [0.03%]
利用溃疡性结肠炎严重指数预测内镜下的改善状况
Emily C L Wong,Parambir S Dulai,John K Marshall et al.
Emily C L Wong et al.
Introduction: We developed and internally validated a prognostic scoring index for ulcerative colitis (UC) patients that includes baseline patient-reported outcomes (PROs), biomarkers, endoscopy, and histology for achievi...
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts [0.03%]
以色列炎症性肠病专家对整合医学的态度调查
Eran Zittan,Hussein Mahajna,Nir Salomon
Eran Zittan
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases [0.03%]
人肠道类器官在炎症性肠病组织修复中的治疗潜力
Duncan Rutherford,Gwo-Tzer Ho
Duncan Rutherford
Inflammatory bowel diseases (IBDs) are chronic immune-mediated conditions characterized by significant gut tissue damage due to uncontrolled inflammation. Anti-inflammatory treatments have improved, but there are no current prorepair approa...
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN [0.03%]
来自epi-IIRN的全国性分析：溃疡性结肠炎患者不予治疗与使用5-ASA的流行率及结局比较
Ohad Atia,Ramit Magen Rimon,Natan Ledderman et al.
Ohad Atia et al.
Background: Data regarding patients with ulcerative colitis (UC) not receiving maintenance treatment are scarce. In this nationwide study, we aimed to explore the frequency and long-term outcomes of untreated patients wit...
Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis [0.03%]
溃疡性结肠炎患者抗TNF-α治疗初始反应的新型mRNA标志物谱系
Xinhui Yang,Jintong Shi,Gaoyang Wang et al.
Xinhui Yang et al.
Background: Ulcerative colitis (UC), an idiopathic, chronic inflammatory disorder of the colonic mucosa, is commonly treated with antitumor necrosis factor α (anti-TNF-α) agents. However, only approximately two-thirds h...